Nestlé has initiated a recall of certain batches of baby formula primarily in Europe due to potential contamination with a toxin that can lead to symptoms such as nausea and vomiting. The recall does not impact any products in Canada, as confirmed by the company.
The recall was undertaken voluntarily by Nestlé for batches of its SMA, BEBA, and NAN infant formulas as a precautionary measure due to concerns about the presence of a toxin known as cereulide in those specific batches. Cereulide is a toxin produced by a specific strain of bacteria that can cause food poisoning, resulting in severe vomiting and nausea for up to 24 hours, as per information from Ireland’s food inspection agency.
Nestlé emphasized its commitment to the safety and well-being of infants, stating that the recall was performed as a precautionary step in line with their stringent product quality and safety standards. The company conducted tests on their products after detecting a quality issue with an ingredient from a supplier. Following the completion of testing, Nestlé has switched to alternative suppliers to increase production and ensure an uninterrupted supply of formula.
Despite the recall affecting various countries such as Turkey, Argentina, the U.K., Ireland, and other European nations, Nestlé assured that there have been no confirmed illnesses linked to the recalled products. Moreover, both Nestlé and the Canadian Food Inspection Agency (CFIA) confirmed that the recall does not impact any products in Canada at this time.
Nestlé has provided a list of affected batch numbers on their website, advising consumers to refrain from using the affected formulas and to contact the company for a refund if they have purchased any of the recalled products. The recall, which began on a smaller scale in December, has put additional pressure on Philipp Navratil, the company’s new chief executive, who aims to drive growth through a portfolio review following a period of management changes.
Austria’s health ministry indicated that the recall impacted over 800 products from more than 10 Nestlé factories and is considered the largest in the company’s history, although these numbers have not been officially confirmed by Nestlé. The Swiss multinational company, which has observed a decline of over three percent in its shares in the last two sessions, holds nearly a quarter of the $92.2 billion global infant nutrition market, according to SkyQuest Technology Group. Infant formula is part of Nestlé’s Nutrition and Health Science division, contributing to 16.6 percent of the company’s total sales in 2024.
In the event that additional information arises or affected products are found in the Canadian market, CFIA will inform the public through its Recalls and Safety Alerts website and issue food recall warnings as necessary, as stated by a spokesperson for the inspection agency.
